摘要
帕金森氏病表述经被改成了“帕金森氏多类疾病”,在一些调查PD存在不同亚型的研究中,其被用来描述从不同临床患者中观察到的表型。PD患者可以根据临床特征分组。只考虑运动症状,可以分为两类:“震颤型”和“运动不便型”,静止震颤、运动不便/运动迟缓和肌僵直分别是二者最主要的特征。非运动症状(NMSs)常常在疾病过程中出现,其中一些症状(便秘、抑郁状态、嗅觉减退和焦虑)甚至在典型的运动症状发作前存在。许多其他的NMSs,尤其是幻觉、认知障碍、睡眠障碍和吞咽困难、在疾病的晚期有极大地影响,当这些症状同时出现,且严重程度不同时,对于治疗是一个真正的挑战。如果没有充分治疗,他们会增加住院治疗的风险和疗养院入院负担,并且极度负面影响着患者们的生活质量和参与社会活动能力。最近联合运动和非运动症状,许多PD亚型被提出。这个分类来源于聚类分析,其根据运动和非运动症状的相关性统计识别不同帕金森患者亚型。在这点上,我们根据聚类症状表现(运动和非运动症状)及使用对PD多类症状起效的药物,提出了一个帕金森氏病的运动和非运动症状的治疗方法示意图。
关键词: 聚类症状,运动症状,非运动症状,帕金森氏病,亚型,治疗
Current Drug Targets
Title:Treatment of the Motor and Non-Motor Symptoms in Parkinson's Disease According to Cluster Symptoms Presentation
Volume: 15 Issue: 10
Author(s): Fulvio Lauretani, Antonio Saginario, Gian Paolo Ceda, Laura Galuppo, Livia Ruffini, Anna Nardelli and Marcello Maggio
Affiliation:
关键词: 聚类症状,运动症状,非运动症状,帕金森氏病,亚型,治疗
摘要: The term Parkinson’s disease has been changed in ‘Parkinson's diseases’ to describe different clinical entities observed in several studies investigating the existence of PD subtypes. PD patients could be grouped based on clinical features. By considering only motor symptoms, we can classically distinguish two groups: “ the tremorigen-form” and “akinetic- rigidity-form” where resting tremor and akinesia/bradikynesia and rigidity are the most motor predominant symptoms, respectively. Non-motor symptoms (NMSs) are practically always present during the course of the disease and some of them (constipation, depressive status, hyposmia and anxiety) could even exist before the onset of classical motor symptoms. Many other NMSs and in particular hallucinations, cognitive impairment, sleep disorders and difficulty in swallowing strongly affect the advanced stage of disease, and represent a real therapeutic challenge when these symptoms are simultaneously present with different severity. If not adequately treated, they can increase the risk of hospitalization and admissions in nursing home, and profoundly and negatively influence the quality of life and participation in social activity of these patients. PD subtypes according to the combination of motor and non-motor symptoms have been recently proposed. This classification derives from cluster analysis which permits to identify statistically distinct subtypes of Parkinsonian patients according to the relevance of both motor and non-motor symptoms. In this point of view, we propose a schematic therapeutic approach of motor and non-motor symptoms in Parkinson’s disease according to cluster symptoms presentation (motor and non-motor symptoms) and using medications that act on multiple domains of PD symptoms.
Export Options
About this article
Cite this article as:
Lauretani Fulvio, Saginario Antonio, Ceda Paolo Gian, Galuppo Laura, Ruffini Livia, Nardelli Anna and Maggio Marcello, Treatment of the Motor and Non-Motor Symptoms in Parkinson's Disease According to Cluster Symptoms Presentation, Current Drug Targets 2014; 15 (10) . https://dx.doi.org/10.2174/1389450115666140826104030
DOI https://dx.doi.org/10.2174/1389450115666140826104030 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
COPD Management: Look Beyond the Airway Obstruction, Chronic Bronchitis and Emphysema
Current Respiratory Medicine Reviews Enhanced Hyperthermia Induced by MDMA in Parkin Knockout Mice
Current Neuropharmacology Inhalation Gases or Gaseous Mediators As Neuroprotectants for Cerebral Ischaemia
Current Drug Targets A Two-layer Model to Identify Hepatitis B Virus Related Chronic Hepatitis and Liver Cirrhosis Based on Plasma microRNA Biomarkers
Combinatorial Chemistry & High Throughput Screening Tuning and Fine-Tuning of Synapses with Adenosine
Current Neuropharmacology Apolipoprotein E4 Serum Concentration for Increased Sensitivity and Specificity of Diagnosis of Drug Treated Alzheimer’s Disease Patients vs. Drug Treated Parkinson’s Disease Patients vs. Age-matched Normal Controls
Current Alzheimer Research On the Role of Endothelial TRPC3 Channels in Endothelial Dysfunction and Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Should Arterial Embolization in Recurrent Spontaneous Hemoph ilic Hemarthroses Refractory to Intensive Prophylaxis be the First Invas ive Resort?
Cardiovascular & Hematological Disorders-Drug Targets The “Parkinsonian Heart”: From Novel Vistas to Advanced Therapeutic Approaches in Parkinsons Disease
Current Medicinal Chemistry Mesenchymal Stem Cells: Use in Cartilage Repair
Current Rheumatology Reviews Cerebrospinal Fluid, Brain Electrolytes Balance, and the Unsuspected Intrinsic Property of Melanin to Dissociate the Water Molecule
CNS & Neurological Disorders - Drug Targets Use of Push-Pull Superfusion Technique for Identifying Neurotransmitters Involved in Brain Functions: Achievements and Perspectives
Current Neuropharmacology Phenolic Compounds from Plants as Nitric Oxide Production Inhibitors
Current Medicinal Chemistry Mitochondria, Mitochondrial DNA and Alzheimers Disease. What Comes First?
Current Alzheimer Research Surgical Treatment of the Sleep Apnea Syndrome in the Twenty-First Century
Current Respiratory Medicine Reviews Neurological Disorders in Medical Use of <i>Cannabis</i>: An Update
CNS & Neurological Disorders - Drug Targets Mind-Body Practices and the Adolescent Brain: Clinical Neuroimaging Studies
Adolescent Psychiatry Genotype-Dependent Differences in Sleep, Vigilance, and Response to Stimulants
Current Pharmaceutical Design Cancer Metastasis: Characterization and Identification of the Behavior of Metastatic Tumor Cells and the Cell Adhesion Molecules, including Carbohydrates
Current Drug Targets - Cardiovascular & Hematological Disorders Recent Patents on Ocular Drug Delivery Systems
Recent Patents on Drug Delivery & Formulation